Orexin receptor 2 (OX2R) agonist for use in narcolepsy type 1 (NT1)
CA3329043A1Undetermined Publication Date: 2025-11-06TAKEDA PHARMA CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3329043
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-04-30
- Filing Date
- 2025-04-30
- Publication Date
- 2025-11-06
Abstract
Disclosed herein are methods, uses and composition for treating narcolepsy with cataplexy (narcolepsy type 1 or NT1), blunted nocturnal blood pressure dip in a subject having narcolepsy type 1 or cognitive impairment in a subject having narcolepsy type 1, by administering an orexin receptor 2 agonist to the subject at one or more daily dosages.
Need to check novelty before this filing date? Find Prior Art
